Single-Use/Disposable Endoscopy Market See Incredible Growth 2021-2030

The global single-use/disposable endoscopy market is witnessing a significant increase in size of the market due to the ongoing COVID-19 pandemic. The overall market was estimated to be $471.7 million in FY2019, and it is expected to grow at a CAGR of 40.17% during the forecast period, 2021-2030. Presently, more than XX companies are operating in this market, including already existing and emerging medical device companies.

Owing to the COVID-19 pandemic, the secondary procedures including endoscopy services were shut down in 2020. However, the pandemic has created a positive impact on the net revenue in single-use endoscopes primarily due to the increase in infectious diseases and increasing awareness among patients regarding concern about hygiene has leaded to increase in demand of single-use endoscopes.

The global single-use/disposable endoscopy market was estimated at $471.7 Million in 2019 and is expected to reach $22,720.1 Million by 2030

Market Challenges

• Dominance of Reusable Endoscope Enterprises

Market Trends

• Growing Adoption of Single-Use Devices

Market Opportunities

• Development of Multipurpose Single-Use/Disposable Endoscope

• Rising Usage of Single-Use/Disposable Endoscope for Bronchoscopy and Hysteroscopy procedures

Key Companies Profiled

3NT Medical Ltd., Ambu A/S, Boston Scientific Corporation, Coloplast A/S, Corinth MedTech, Inc., Hill-Rom Holdings, Inc., HOYA Corporation, Integra LifeSciences Holdings Corporation, Integrated Endoscopy, KARL STORZ SE& CO.KG, OBP Medical Corporation, OUT Medical INC., PArburch Medical Developments Ltd., and Prosurg Inc.

Key Questions Answered in this Report:

•   What are the key regulations abiding the development, commercialization, and clinical-use of single-use/disposable endoscope, across different regions?
•   What are the key technological developments on which the current industry leaders are spending their major share of research and development (R&D) investment?
•   Who are the leading players which hold significant dominance on the global single-use/disposable endoscope market, currently?
•   What are the key strategies incorporated by the players of the global single-use/disposable endoscope market, to sustain the competition and retain their supremacy?
•   What is the current annual demand for a single-use/disposable endoscope across different regions and its growth potential in the forecast period?
•   What is the current market potential of single-use/disposable endoscope and what are the factors deciding the growth potential of a single-use/disposable endoscope, in the forecast period?
•   What is the current revenue contribution of different applications and how would it evolve in the forecast period?
•   What are the products in the pipeline, expected to be launched during the forecast period?
•   What is the difference between a reusable endoscope and a single-use endoscope?
•   What is the current demand contribution of different end-user types and how would it evolve in the forecast period?
•   Which countries contribute to the major share of current demand and which countries hold significant scope for expansion for business activities, by players of the global single-use/disposable endoscopy market?

Request a Sample- https://bisresearch.com/requestsample?id=1047&type=download

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing microbiome therapeutics market is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...

Digital PCR Market size,Share, Leading Players, Growth, Development and Demand Forecast to 2032

Increasing investments in R&D for d-PCR molecular diagnostics is one of the major opportunities in the global digital PCR market. Several biotechnology and life sciences companies are working collaboratively on diagnostic test development and using d-PCR as a therapeutic means for applications in several disease indications to enable efficient diagnosis, treatment selection, and treatment monitoring. The global digital PCR market is projected to reach $2,847.8 million by 2032 from $441.2 million in 2021, at a CAGR of 18.73% during the forecast period 2022–2032. The growth in the global digital PCR market is expected to be driven by factors such as the increasing prevalence of infectious and genetic diseases globally, the rising awareness of d-PCR-based diagnostic testing, and the significant number of funding for executing research and development. Impact of COVID-19 The current global digital PCR market comprises kits and assays, system, and reagents and consuma...

Radiation Dose Management Market Likely To Increase Size, Shares, And Demand Forecast 2022-2032

Radiation dose is the amount of radiation absorbed by a patient during a diagnostic imaging procedure. A large dose of radiation can cause tissue damage and increase the risk of developing cancer in later stages of life.The development of on-cloud dose management solutions and the growing initiatives on radiation dose management for pediatric procedures are some of the major opportunities in the global radiation dose management market. Furthermore, some of the key trends going on in the market include the increasing development of imaging modalities with technologies that lower radiation dose, partnerships and strategic business alliances dominating the market, and various collaborations among market players. The global radiation dose management market was valued at $212.8 million in 2021 and is anticipated to reach $586.7 million by 2032, witnessing a CAGR of 10.30% during the forecast period 2022–2032. The growth in the global radiation dose management market is ex...

Market Research Reports

Search This Blog